Archives
-
Sex Differences in Angiotensin II Hypertension
2026-09-07
Xue, Pamidimukkala, and Hay used telemetry in conscious, freely moving mice to show that chronic angiotensin II causes a much larger blood-pressure increase in males than females despite comparable baseline pressure. Gonadectomy, baroreflex testing, and ganglionic blockade linked this divergence to sex-dependent hormonal and sympathetic regulation rather than baseline hemodynamics alone.
-
Protein A/G Magnetic Beads for Mechanistic IP
2026-09-05
Protein A/G Magnetic Beads connect Fc-directed antibody capture with rigorous pathway validation. This article shows how recombinant Protein A and Protein G beads can clarify MAPK1/HMOX1-related mechanisms while controlling background in IP, Co-IP, and Ch-IP workflows.
-
IGF2BP3–FZD1/7 Axis in TNBC Carboplatin Resistance
2026-09-04
The reference study identifies IGF2BP3 as an m6A reader that stabilizes FZD1 and FZD7 transcripts, activates β-catenin signaling, and sustains stem-like properties in triple-negative breast cancer. Its integrated molecular and pharmacological evidence suggests that disrupting the IGF2BP3–FZD1/7 axis may improve carboplatin sensitivity, although the findings remain preclinical.
-
α-Amanitin and the Logic of Chromatin Transcription
2026-09-04
A translational framework for using α-Amanitin to connect RNA polymerase II activity with SAFB–satellite RNA control of heterochromatin architecture.
-
Toremifene Citrate: Applied ER Assay Workflows
2026-09-03
Build more interpretable estrogen receptor assays with a workflow that connects receptor affinity, cell proliferation, signaling readouts, and translational tumor models. This guide shows how Toremifene Citrate supports dose selection, ERα/ERβ comparison, assay troubleshooting, and evidence-based comparison with tamoxifen.
-
Fenipentol Workflows for GI and Liver Research
2026-09-03
Fenipentol, also called 1-Phenyl-1-pentanol, is a practical probe for connecting hepatobiliary secretion, ESR1-linked signaling, and inflammation-focused assays. This guide separates established product information from exploratory workflows and highlights a critical distinction between Fenipentol and the positional isomer 1-Phenyl-2-Pentanol.
-
Resiquimod (R-848) in Tumor Ablation Research
2026-09-02
Resiquimod (R-848) provides a practical way to connect TLR7/8 activation with thermal ablation, immunogenic cell death, and local tumor immune remodeling. This guide translates the MR@CaP@HA hydrogel findings into bench workflows, assay controls, formulation choices, and troubleshooting strategies for cancer immunotherapy research.
-
15-PGDH Inhibition Preserves Muscle During Semaglutide
2026-09-02
A 2026 PNAS study shows that 15-PGDH inhibition improves muscle stem cell activity, myofiber regeneration, and force recovery during semaglutide-associated weight loss in obese mice. The findings suggest that targeting impaired muscle repair may preserve functional tissue quality without diminishing the weight-loss effect of GLP-1 receptor agonism.
-
Early Pheromone Sensing and Neurodegeneration in C. elegans
2026-09-01
Peng et al. show that pheromone exposure during the L1 stage can reconfigure neural development and accelerate neurodegeneration later in adult C. elegans. Their work defines a circuit-level mechanism in which ascr#3 and ascr#10 converge through ASK, ASI, and AIA neurons to activate insulin-like signaling and suppress neuronal autophagy.
-
Stable Isotope UHPLC–MS/MS for Methylated Purines
2026-09-01
Zhang, Zhang, and Wang developed a stable isotope-diluted UHPLC–ESI-MS/MS method for accurately quantifying methylated purine nucleosides in cellular samples. Ammonium bicarbonate-assisted ionization, chromatographic separation of isomers, and methanol–SPE cleanup improved sensitivity and enabled measurement of low-abundance modified nucleosides in 293T cells.
-
Polyethylenimine Linear: PEI MW 40,000 Guide
2026-08-31
A scenario-based laboratory guide to using Polyethylenimine Linear (PEI), MW 40,000 (SKU K1029) when transfection, viability, proliferation, and cytotoxicity data must be interpreted together. It explains mechanism, assay controls, optimization, cross-cell-line use, and practical vendor-selection criteria.
-
Cannabidiol, Orofacial Pain, and Serotonergic Circuits
2026-08-31
The 2026 Brain Research Bulletin study shows that cannabidiol reduces inflammatory pain while also improving anxiety-like, depression-like, and cognitive deficits in mouse models. Its main contribution is a mechanistic framework linking peripheral CB2 signaling, central CB1-associated endocannabinoid changes, and altered serotonin activity in the central amygdala.
-
DZNep Assay Design: From Epigenetic Signal to Phenotype
2026-08-30
Explore how 3-Deazaneplanocin (DZNep) connects SAHH inhibition, EZH2 depletion, chromatin remodeling, and context-dependent cancer phenotypes. This guide applies lessons from CHK1 heterogeneity research to build more discriminating AML, HCC, and metabolic-model assays.
-
GluN2A/2B Signaling in TMJ Inflammatory Allodynia
2026-08-29
The reference study identifies distinct roles for GluN2A and GluN2B NMDA receptor subunits in regulating connexin and pannexin signaling within the trigeminal ganglion during temporomandibular joint inflammation. Using conditional genetic deletion, behavioral testing, satellite glial cell assays, and pathway perturbation, the authors connect NMDAR activity with peripheral sensitization and orofacial mechanical allodynia.
-
Firefly Luciferase mRNA for Translational Benchmarking
2026-08-28
A thought-leadership guide to using Cap1, 5-moUTP, and poly(A) design to build more interpretable mRNA delivery studies. The article connects reporter expression with sex-aware preclinical study design and shows how EZ Cap™ Firefly Luciferase mRNA (5-moUTP) can support rigorous translational benchmarking without overinterpreting luminescence as an immune or therapeutic endpoint.